Government of Canada
Symbol of the Government of Canada

Title:

Development of a reverse Cumate transactivator (rcTA): application for protein production in CHO cells. Also called: Expression system, components thereof and method of use

NRC no.:

11648

Sector(s):

Bioprocess

Inventors:

Massie, Bernard; Mullick, Alaka; Xu, Yan.

Status:

United States, Application number 60/614,992, Filed 2004-03-10
Singapore, Patent number 130667, Filed 2005-03-10
Canada, Application number 2,580,515, Filed 2005-10-03
United States, Application number 11/575,621, Filed 2005-10-03
European Common Market, Application number 05791567.0, Filed 2005-10-03
Patent Cooperation Treaty, Patent number WO 2006/037215, Filed 2005-10-03
United States, Application number CIP 12/331,786, Filed 2008-12-10

LOD

Licensing Opportunity Available

Abstract:

Recently, the development of inducible expression systems has involved exploitation of the p-cym operon from Pseudomonas putida. Disclosed herein are novel expression systems and components thereof, which involve the development of CymR variants with reverse DNA binding activity, such that they exhibit increased affinity for DNA in a presence rather than an absence of an effector molecule such as cumene or an equivalent thereof. Also disclosed are the CymR variants, fusion proteins incorporating such variants, and their use in the control and expression of polynucleotides.


For more information, please contact:

Christine St-Jean
Intellectual Property Coordinator, Industrial Affairs
E-mail: christine.st-jean@cnrc-nrc.gc.ca

Note: Data on abstracts is shown in the official language in which it was submitted.